Format

Send to

Choose Destination
J Neuropsychiatry Clin Neurosci. 1996 Spring;8(2):223-6.

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Abstract

Tritiated haloperidol and tritiated dopamine label postsynaptic dopamine receptors in mammalian brain. Clinical potencies of butyrophenones, phenothiazines, and related drugs correlate closely with their ability to inhibit tritiated haloperidol binding. These binding methods provide a simple in vitro means for evaluating new drugs as potential antischizophrenic agents.

PMID:
9081563
DOI:
10.1176/jnp.8.2.223
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center